BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 20132202)

  • 1. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
    Eden CG; Arora A; Rouse P
    BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The learning curve for laparoscopic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer: implications for compliance with existing guidelines.
    Eden CG; Zacharakis E; Bott S
    BJU Int; 2013 Aug; 112(3):346-54. PubMed ID: 23419154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
    Heidenreich A; Ohlmann CH; Polyakov S
    Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.
    Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G
    Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
    Lattouf JB; Beri A; Jeschke S; Sega W; Leeb K; Janetschek G
    Eur Urol; 2007 Nov; 52(5):1347-55. PubMed ID: 17507150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.
    Liss MA; Palazzi K; Stroup SP; Jabaji R; Raheem OA; Kane CJ
    World J Urol; 2013 Jun; 31(3):481-8. PubMed ID: 23512231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic biopsy undergrading: the feasibility of secondary laparoscopic pelvic lymphadenectomy.
    Hellawell G; Ramírez-Backhaus M; Rabenalt R; Do M; Dietel A; Stolzenburg JU
    Urol Int; 2010; 85(2):139-42. PubMed ID: 20516675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: Assessing nodal yield, perioperative outcomes, and complications.
    Zorn KC; Katz MH; Bernstein A; Shikanov SA; Brendler CB; Zagaja GP; Shalhav AL
    Urology; 2009 Aug; 74(2):296-302. PubMed ID: 19515403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE.
    Berglund RK; Sadetsky N; DuChane J; Carroll PR; Klein EA
    J Urol; 2007 Feb; 177(2):526-29; discussion 529-30. PubMed ID: 17222625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
    Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE
    Eur Urol; 2006 Aug; 50(2):272-9. PubMed ID: 16632187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Suardi N; Gallina A; Da Pozzo LF; Roscigno M; Zanni G; Valiquette L; Rigatti P; Montorsi F; Karakiewicz PI
    Eur Urol; 2006 Nov; 50(5):1006-13. PubMed ID: 16959399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized and simplified extended pelvic lymph node dissection during robot-assisted radical prostatectomy: the monoblock technique.
    Mattei A; Di Pierro GB; Grande P; Beutler J; Danuser H
    Urology; 2013 Feb; 81(2):446-50. PubMed ID: 23374827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.